Anakinra in the treatment of rheumatoid arthritis and other IL-1-driven conditions

ISSN： 1746-0816

Source： Future Rheumatology, Vol.2, Iss.4, 2007-08, pp. : 353-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-IL-1α autoantibodies in early rheumatoid arthritis

By Forslind Kristina Svensson BjoÈrn Svenson Morten Bendtzen Klaus

Scandinavian Journal of Rheumatology, Vol. 30, Iss. 3, 2001-05 ,pp. : 167-168

Informa Healthcare

Access to resources Recommend Favorite

Treatment of elderly rheumatoid arthritis

By Tutuncu Zuhre Kavanaugh Arthur

Future Rheumatology, Vol. 2, Iss. 3, 2007-06 ,pp. : 313-319

Future Medicine

Access to resources Recommend Favorite

Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra

By Botsios C. Sfriso P. Punzi L. Todesco S.

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 3, 2007-01 ,pp. : 236-237

Informa Healthcare

Access to resources Recommend Favorite

Treatment of the elderly rheumatoid arthritis patient

By Melikterminas Edward Ranganath Veena Furst Daniel E

Future Rheumatology, Vol. 3, Iss. 3, 2008-06 ,pp. : 235-238

Future Medicine

Access to resources Recommend Favorite

Treatment of Rheumatoid Arthritis with a Peptide Diet

By Holst-Jensen S.E Pfeiffer-Jensen M Monsrud M Tarp U Buus A Hessov I Thorling E Stengaard-Pedersen K

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 5, 1998-10 ,pp. : 329-336

Informa Healthcare

Access to resources Recommend Favorite